ALBANY MOLECULAR RESEARCH INC
10-Q, EX-27.1, 2000-11-14
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: ALBANY MOLECULAR RESEARCH INC, 10-Q, 2000-11-14
Next: EBAY INC, 10-Q/A, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      16,589,721
<SECURITIES>                                14,743,113
<RECEIVABLES>                                7,480,787
<ALLOWANCES>                                   110,000
<INVENTORY>                                  1,389,090
<CURRENT-ASSETS>                            49,615,254
<PP&E>                                      24,386,975
<DEPRECIATION>                               5,754,942
<TOTAL-ASSETS>                             109,587,088
<CURRENT-LIABILITIES>                        7,285,723
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       297,392
<OTHER-SE>                                 102,003,973
<TOTAL-LIABILITY-AND-EQUITY>               109,587,088
<SALES>                                      9,890,413
<TOTAL-REVENUES>                            17,358,661
<CGS>                                        5,506,489
<TOTAL-COSTS>                                8,709,081
<OTHER-EXPENSES>                               729,847
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              9,379,426
<INCOME-TAX>                                 3,553,629
<INCOME-CONTINUING>                          5,825,798
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 5,825,798
<EPS-BASIC>                                       0.20
<EPS-DILUTED>                                     0.19


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission